Literature DB >> 20464042

Proteomic analysis of clear cell renal cell carcinoma. Identification of potential tumor markers.

Chuan Y Sun1, Ya C Zang, Yu X San, Wei Sun, Liang Zhang.   

Abstract

OBJECTIVE: To identify new tumor specific proteins of renal cell carcinoma (RCC) using proteomic analysis.
METHODS: Nine renal cell carcinomas were resected and these surgical operations were carried out from June 2007 to September 2008 in the Urology Department of the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China. The cancer tissues and para-cancer normal tissues were preserved in liquid nitrogen. We analyzed the RCC tissues and para-cancer normal tissues by 2-dimensional polyacrylamide gel electrophoresis (2D-PAGE). The 16 differentially expressed protein spots (p<0.05 by Student t-test) were identified by matrix assisted laser desorption ionization/time of flight mass spectrometry and tandem mass spectrometry.
RESULTS: Six proteins were down regulated and 10 proteins were up regulated in clear cell RCC compared with corresponding normal kidney tissue. The down regulated proteins were calbindin, ester hydrolase C11orf54, alcohol dehydrogenase, ammecr1-like protein, adenosine diphosphate (ADP)/adenosine-5'-triphosphate (ATP) translocase 3 and leucine-tyrosine-arginine (LYR) motif-containing protein 5. The up regulated proteins were hypoxia inducible domain family member 1A, glutathione S-transferase P, thioredoxin-dependent peroxide reductase, peroxiredoxin-6, CD2-associated protein, annexin A5, gamma-enolase, retinal dehydrogenase 1, vimentin, and protein-glutamine gamma-glutamyltransferase 2.
CONCLUSION: The data provide potential tumor markers for diagnosis of RCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20464042

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  8 in total

Review 1.  Urine metabolomics for kidney cancer detection and biomarker discovery.

Authors:  Sheila Ganti; Robert H Weiss
Journal:  Urol Oncol       Date:  2011 Sep-Oct       Impact factor: 3.498

2.  Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma.

Authors:  Edward Sanders; Svenja Diehl
Journal:  Oncoscience       Date:  2015-02-17

3.  CD133 expression in renal cell carcinoma (RCC) is correlated with nuclear hypoxia-inducing factor 1α (HIF-1α).

Authors:  Chuanyang Sun; Hui Song; Hua Zhang; Chuansheng Hou; Tianhang Zhai; Lv Huang; Liang Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2012-05-22       Impact factor: 4.553

4.  Computational Recognition of a Regulatory T-cell-specific Signature With Potential Implications in Prognosis, Immunotherapy, and Therapeutic Resistance of Prostate Cancer.

Authors:  Mingyi Ju; Jingyi Fan; Yuanjiang Zou; Mingjie Yu; Longyang Jiang; Qian Wei; Jia Bi; Baohui Hu; Qiutong Guan; Xinyue Song; Mingyan Dong; Lin Wang; Lifeng Yu; Yan Wang; Hui Kang; Wei Xin; Lin Zhao
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

5.  DiPhiSeq: robust comparison of expression levels on RNA-Seq data with large sample sizes.

Authors:  Jun Li; Alicia T Lamere
Journal:  Bioinformatics       Date:  2019-07-01       Impact factor: 6.937

6.  Application of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry technology for the diagnosis of colorectal adenoma.

Authors:  Zhong-Yin Zhou; DI-DI Tao; Ji-Wang Cao; He-Sheng Luo
Journal:  Oncol Lett       Date:  2013-04-15       Impact factor: 2.967

7.  Establishment and characterization of a highly immunogenic human renal carcinoma cell line.

Authors:  Clelia Prattichizzo; Margherita Gigante; Paola Pontrelli; Alessandro Stella; Maria Teresa Rocchetti; Maddalena Gigante; Eugenio Maiorano; Wolfgang Herr; Michele Battaglia; Loreto Gesualdo; Elena Ranieri
Journal:  Int J Oncol       Date:  2016-05-27       Impact factor: 5.650

8.  Renal peroxiredoxin 6 interacts with anion exchanger 1 and plays a novel role in pH homeostasis.

Authors:  Sara L Sorrell; Zoe J Golder; Duncan B Johnstone; Fiona E Karet Frankl
Journal:  Kidney Int       Date:  2016-01-04       Impact factor: 10.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.